EV maker Tesla ($TSLA) is in a transition phase, according to Yahoo Finance’s Opening Bid interview with Gradient Investments ...

Tesla's Q2 results confirmed deteriorating fundamentals: deliveries and revenue declined, margins compressed. Read why I rate ...

The fallout could be seen in Tesla's Q2 numbers, while tariffs also stung the company. Meanwhile, it will soon see an even potentially bigger headwind due to the expiration of the U.S. electric ...

Shares of beleaguered drugmaker Sarepta Therapeutics jumped in afterhours trading Monday after the company said it would ...

You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy. This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply.

The company almost faced legal issues for not holding a shareholder meeting within 13 months of its previous one. Tesla hit with backlash from key shareholders ahead of pivotal meeting: 'Particularly ...